Emerging drugs for the treatment of postsurgical pain

ABSTRACT

Introduction

Postoperative pain is a distressful experience and remains to be a significant concern after surgery. Current agents either fail to prevent or minimize postoperative pain or cause a series of adverse effects, addiction, or abuse. Opioids have been the gold standard in the treatment of postoperative pain despite their well-described adverse effects. Many new agents with different mechanisms of action have been recently introduced to address this issue.

Areas covered

This current review summarizes the list of new and emerging drugs investigated for their efficacy in controlling the postoperative pain and decreasing the need for rescue opioid use, adverse effect profile, abuse, and addiction potential.

Expert opinion

Opioids have unrivaled analgesic efficacy. However adverse effects of opioids led to the search for better options. In mild pain most of the emerging drugs have been shown to control postoperative pain and decrease the use of rescue opioid, however fail to control pain after major surgeries causing severe pain. Specific agents such as Oliceridine, new local anesthetics, etc., are effective in controlling severe pain and hold a promise to replace opioids in the near future.

KEYWORDS:

• Postoperative pain
• opioid
• emerging drugs
• multi-modal analgesia

Funding

This paper was not funded.

Declaration of interest

A Turan received investigator-initiated research grant for Pacira, is investigator in Heron sponsored trial, and is a speaker for Pfizer.